When the individual delta (difference between pre-transplant and 8-h reperfusion sample) was calculated, a significantly smaller ischemia-associated rise of the cystatin C serum levels in the Bryostatin-1-treated group was found (Figure 8F). This evidence concerns the gene CST3 and ischemia.